LALPATHLAB — Dr. Lal PathLabs Share News
0.000.00%
Last trade - 00:00- IN₹311.00bn
- IN₹299.44bn
- IN₹27.63bn
Brief: India's Dr. Lal Pathlabs Sept-Quarter Consol Net Profit Rises
Media: Dr. Lal PathLabs, one of India’s largest blood test labs, exposed patient data - TechCrunch
Brief: India's Dr. Lal Pathlabs June Qtr Consol Net Profit Falls
Brief: Dr. Lal Pathlabs Says Adverse Impact Of Lockdown On Co's Revenue Seen Until Q2 FY21
Brief: Dr. Lal Pathlabs March Qtr Consol Net Profit Falls
Brief: ICMR Empanels Dr. Lal Pathlabs' Rohini, New Delhi Lab For COVID-19 Testing
Board Approved Scheme Of Amalgamation Of Unit With Co
Appointed Om Prakash Manchanda As Managing Director For Five Years
Brief: India's Dr. Lal Pathlabs Dec Qtr Consol Net Profit Rises
Brief: Dr. Lal Pathlabs Declares Interim Dividend Of 6 Rupees Per Share
Brief: India's Dr. Lal Pathlabs Sept Quarter Consol Net Profit Rises
Brief: India's Dr. Lal Pathlabs Dec-Qtr Net Profit Rises
BSE Block Deal DR. LAL PATH-A 55,383 shares at 910.00 INR
Brief: Dr. Lal Pathlabs Says NCLT Sanctioned Scheme Of Amalgamation With Delta Ria And Pathology
Brief: India's Dr. Lal Pathlabs Sept-Qtr Consol Profit Rises
Brief: Dr. Lal Pathlabs Says NCLT Sanctions Scheme Of Amalgamation Between Co, Delta Ria And Pathology
Brief: Dr. Lal Pathlabs Says Approved Appointment Of Ved Prakash Goel As CFO
Brief: India's Dr. Lal Pathlabs June-Qtr Consol Net Profit Rises
Brief: Dr. Lal Pathlabs Says Dilip Bidani Resigns As CFO